National Vision Q2 2026 Earnings: SG&A Leverage Lifts Adjusted Margin to 6.3%

TradingKey
Aug 12

National Vision (NASDAQ: EYE) reported fiscal Q2 2026 net revenue of $498.8 million, up 2.5% year over year, while diluted EPS increased to $0.15 from $0.11. Profitability improved as lower associate-related and advertising expenses reduced SG&A, more than offsetting a higher cost-of-revenue ratio. Adjusted operating income rose 32.7% to $31.6 million.

Core results

Revenue growth for the quarter ended July 4, 2026 was supported by new stores, adjusted comparable-store sales growth and a 0.8% benefit from the timing of unearned revenue. Store closures provided a partial offset.

The earnings improvement was faster than revenue growth. Net income increased to $12.4 million, while adjusted operating margin expanded by 140 basis points as SG&A declined both in dollars and as a percentage of revenue.

MetricQ2 2026Q2 2025Year-over-year change
Net revenue$498.8 million+2.5%
Net income$12.4 million$8.7 millionApprox. +42.5%
Net income margin2.5%1.8%+70 bps
Diluted EPS$0.15$0.11Approx. +36.4%
Adjusted operating income$31.6 million$23.8 million+32.7%
Adjusted operating margin6.3%4.9%+140 bps
Adjusted diluted EPS$0.25$0.18Approx. +38.9%

Adjusted operating income, adjusted operating margin and adjusted diluted EPS are non-GAAP measures. The timing of unearned revenue benefited net income by $2.2 million, adjusted operating income by $2.9 million, and both diluted and adjusted diluted EPS by $0.03.

Business and store performance

Comparable-store sales grew 3.4%, while adjusted comparable-store sales growth was 2.2%. Higher average tickets and continued strength among managed care customers supported sales, partially offset by lower traffic from self-pay customers.

National Vision opened nine new America’s Best stores and closed two during the quarter. It finished the period with 1,281 stores, representing overall store-count growth of 3.3%.

Management described the shift toward higher-value transactions, managed care customers and an improved product mix as part of its effort to build a more profitable customer base. The company also completed its website replatforming, creating a unified commerce foundation intended to connect eye exams, prescriptions and retail purchases.

SG&A leverage outweighed higher product costs

Costs applicable to revenue increased 4.0% to $208.4 million, faster than revenue growth. These costs rose to 41.8% of revenue from 41.2%, with the 60-basis-point increase attributed to a strategic mix shift toward higher-value products.

SG&A moved in the opposite direction, declining 1.5% to $243.4 million. As a percentage of revenue, SG&A fell 200 basis points to 48.8%, mainly because of lower associate-related expenses, including variable incentive compensation, and lower advertising spending. Higher occupancy expense was a partial offset.

Adjusted SG&A declined 1.6% to $236.2 million and fell to 47.3% of revenue from 49.3%. This expense leverage was large enough to absorb the higher product-cost ratio and still produce a meaningful increase in adjusted operating margin.

Balance sheet and capital allocation

National Vision ended the quarter with $36.0 million in cash and $237.7 million in total debt. It had no borrowings outstanding under its $300.0 million first-lien revolving credit facility, excluding $6.7 million of letters of credit.

The company repurchased approximately 1.2 million shares for $20.0 million during the quarter. Its share-repurchase authorization had $30.0 million of remaining capacity as of July 4, 2026.

Fiscal 2026 guidance

National Vision narrowed the upper end of its adjusted comparable-store sales growth outlook to 5.0% from 6.0%, while leaving the 3.0% lower bound unchanged. The company maintained its new-store target and lowered and narrowed its planned capital expenditure range.

MetricUpdated FY2026 outlookPrior outlookChange
New stores30-3530-35Unchanged
Adjusted comparable-store sales growth3.0%-5.0%3.0%-6.0%Upper end reduced
Capital expenditures$72-$76 million$73-$78 millionLowered and narrowed

The outlook covers the 52 weeks ending January 2, 2027. The new-store plan primarily assumes America’s Best openings and excludes the 20 Military store additions completed in April 2026.

Risks investors should monitor

  • Continued weakness in self-pay traffic: Higher tickets and managed care growth offset lower self-pay customer traffic this quarter, but persistent traffic declines could limit comparable-store sales growth.
  • Pressure from product mix: The move toward higher-value products raised costs applicable to revenue as a percentage of sales. Further adjusted-margin expansion depends partly on maintaining enough SG&A leverage to offset this pressure.
  • Unearned-revenue timing: Timing added 0.8% to quarterly revenue and contributed $2.9 million to adjusted operating income. This benefit affects comparability and means not all of the reported earnings growth came from underlying operations.
  • Potential expense normalization: Lower advertising and variable incentive compensation helped Q2 margins, while occupancy costs increased. Management also plans greater marketing investment in the second half, making the future SG&A trajectory important.

Summary

National Vision’s second quarter combined modest revenue growth with faster earnings growth, driven primarily by SG&A discipline, higher average tickets and managed care demand. The central questions for upcoming quarters are whether the company can sustain expense leverage, stabilize self-pay traffic and deliver growth within its narrower adjusted comparable-store sales range while continuing its store and digital initiatives.

Find out more

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10